Total Payments
$844,151
2024 Payments
$153,175
Companies
29
Transactions
824
Medicare Patients
234
Medicare Billing
$16,421
Payment Breakdown by Category
Other$616,388 (73.0%)
Consulting$145,592 (17.2%)
Travel$39,982 (4.7%)
Food & Beverage$26,222 (3.1%)
Research$15,837 (1.9%)
Education$131.05 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $578,217 | 245 | 68.5% |
| Consulting Fee | $145,592 | 69 | 17.2% |
| Travel and Lodging | $39,982 | 112 | 4.7% |
| Honoraria | $38,171 | 21 | 4.5% |
| Food and Beverage | $26,222 | 358 | 3.1% |
| Unspecified | $15,837 | 15 | 1.9% |
| Education | $131.05 | 4 | 0.0% |
Payments by Type
General
$828,315
809 transactions
Research
$15,837
15 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $177,692 | 217 | $0 (2024) |
| GENZYME CORPORATION | $144,637 | 100 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $124,406 | 107 | $0 (2024) |
| GlaxoSmithKline, LLC. | $104,165 | 75 | $0 (2024) |
| CSL Behring | $92,108 | 76 | $0 (2024) |
| Genentech USA, Inc. | $81,704 | 95 | $0 (2024) |
| Aimmune Therapeutics, Inc. | $28,982 | 17 | $0 (2022) |
| Regeneron Pharmaceuticals, Inc. | $27,962 | 32 | $0 (2024) |
| F. Hoffmann-La Roche AG | $14,190 | 13 | $0 (2024) |
| Amgen Inc. | $12,335 | 12 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $153,175 | 129 | AstraZeneca Pharmaceuticals LP ($42,990) |
| 2023 | $166,385 | 135 | AstraZeneca Pharmaceuticals LP ($42,502) |
| 2022 | $133,507 | 113 | Regeneron Healthcare Solutions, Inc. ($35,926) |
| 2021 | $157,864 | 122 | GENZYME CORPORATION ($33,262) |
| 2020 | $65,310 | 84 | Regeneron Healthcare Solutions, Inc. ($17,489) |
| 2019 | $97,502 | 98 | CSL Behring ($27,316) |
| 2018 | $54,727 | 95 | AstraZeneca Pharmaceuticals LP ($24,206) |
| 2017 | $15,682 | 48 | Regeneron Pharmaceuticals, Inc. ($10,245) |
All Payment Transactions
824 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $2,532.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $111.73 | General |
| Category: Immunology | ||||||
| 12/13/2024 | CSL Behring | Hizentra (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: Immunology | ||||||
| 12/13/2024 | CSL Behring | Hizentra (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: Immunology | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,200.00 | General |
| Category: Respiratory | ||||||
| 12/06/2024 | Genentech USA, Inc. | Xolair (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: Immunology | ||||||
| 11/27/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,879.50 | General |
| 11/21/2024 | Genentech USA, Inc. | Xolair (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: Immunology | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,150.00 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $111.68 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $146.32 | General |
| Category: Immunology | ||||||
| 11/09/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $61.07 | General |
| Category: Immunology | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,148.00 | General |
| 11/05/2024 | CSL Behring | Hizentra (Biological) | Consulting Fee | Cash or cash equivalent | $3,330.00 | General |
| Category: Immunology | ||||||
| 10/27/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $83.24 | General |
| Category: Immunology | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,200.00 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $111.68 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: Immunology | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $115.65 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Travel and Lodging | In-kind items and services | $89.78 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $24.62 | General |
| 10/01/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | — | In-kind items and services | $717.95 | Research |
| Study: DUPIXENT CLINICAL DEVELOPMENT PROGRAM • Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/30/2024 | F. Hoffmann-La Roche AG | Xolair (Biological) | — | In-kind items and services | $4,640.78 | Research |
| Study: SAFETY PROFILE OF XOLAIR IN THE POST MARKETING SETTING A SUBANALYSIS OF THE PROSPERO STUDY • Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| SAFETY PROFILE OF XOLAIR IN THE POST MARKETING SETTING A SUBANALYSIS OF THE PROSPERO STUDY | F. Hoffmann-La Roche AG | $5,802 | 3 |
| Effect of Omalizumab on Asthma Outcomes in Adolescents/Adults with Asthma and Food Allergy | F. Hoffmann-La Roche AG | $3,296 | 4 |
| Impact Of Food Allergy On Work Productivity And Healthcare Resource Use In Patients With Allergic Asthma Treated With Omalizumab | F. Hoffmann-La Roche AG | $2,768 | 3 |
| Effect of Omalizumab on Asthma Outcomes in Pediatric Patients with Asthma and Food Allergy | F. Hoffmann-La Roche AG | $2,325 | 3 |
| ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | Regeneron Pharmaceuticals, Inc. | $928.64 | 1 |
| DUPIXENT CLINICAL DEVELOPMENT PROGRAM | Regeneron Pharmaceuticals, Inc. | $717.95 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 61 | 73 | $14,860 | $3,751 |
| 2022 | 2 | 48 | 58 | $12,337 | $4,235 |
| 2021 | 3 | 70 | 73 | $14,058 | $4,932 |
| 2020 | 3 | 55 | 63 | $11,274 | $3,503 |
Total Patients
234
Total Services
267
Medicare Billing
$16,421
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 49 | $14,029 | $3,363 | 24.0% |
| 99447 | Telephone or internet assessment with verbal and written report by consulting physician, 11-20 minutes | Facility | 2023 | 11 | 11 | $651.53 | $305.25 | 46.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 12 | 13 | $179.53 | $82.94 | 46.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 36 | 46 | $9,170 | $3,119 | 34.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $3,167 | $1,116 | 35.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 35 | 38 | $6,536 | $2,676 | 40.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 22 | 22 | $5,806 | $1,662 | 28.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 13 | $1,716 | $593.89 | 34.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 31 | 39 | $6,708 | $2,177 | 32.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $3,167 | $896.48 | 28.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 12 | $1,399 | $429.38 | 30.7% |
About Dr. Syed Mustafa, MD
Dr. Syed Mustafa, MD is a Allergy & Immunology healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1619023223.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Syed Mustafa, MD has received a total of $844,151 in payments from pharmaceutical and medical device companies, with $153,175 received in 2024. These payments were reported across 824 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($578,217).
As a Medicare-enrolled provider, Mustafa has provided services to 234 Medicare beneficiaries, totaling 267 services with total Medicare billing of $16,421. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Location Rochester, NY
- Active Since 01/26/2007
- Last Updated 03/25/2020
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1619023223
Products in Payments
- DUPIXENT (Biological) $252,760
- Xolair (Biological) $75,956
- NUCALA (Biological) $73,744
- Hizentra (Biological) $72,379
- TEZSPIRE (Biological) $53,204
- FASENRA (Drug) $45,988
- PALFORZIA (Biological) $23,707
- FASENRA (Biological) $22,785
- DUPIXENT DUPILUMAB INJECTION (Biological) $22,690
- TRELEGY ELLIPTA (Drug) $21,023
- AIRSUPRA (Drug) $17,031
- Privigen (Biological) $15,814
- DUPIXENT (Drug) $14,132
- EVUSHELD (Drug) $8,905
- XOLAIR (Drug) $7,676
- Oralair (Drug) $2,586
- CUVITRU (Biological) $1,069
- XOLAIR (Biological) $1,015
- Odactra (Drug) $1,000
- Xembify (Biological) $322.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in Rochester
Dr. Douglas Jones, M.d, M.D
Allergy & Immunology — Payments: $53,112
Allergy & Immunology $53,112
Thanai Pongdee, Md, MD
Allergy & Immunology — Payments: $43,985
Allergy & Immunology $43,985
Elina Jerschow, Md, MD
Allergy & Immunology — Payments: $41,960
Allergy & Immunology $41,960
Dr. Jennifer Barnas, M.d., Ph.d, M.D., PH.D
Allergy & Immunology — Payments: $20,781
Allergy & Immunology $20,781
James Li, M.d, M.D
Allergy & Immunology — Payments: $7,994
Allergy & Immunology $7,994
Dr. Ulrich Ringwald, Md, MD
Allergy & Immunology — Payments: $5,986
Allergy & Immunology $5,986